Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Apr;21(2):121-31.
doi: 10.1089/cap.2010.0047. Epub 2011 Apr 13.

Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder

Sharon B Wigal  1 , Tim Wigal, Sabrina Schuck, Matthew Brams, David Williamson, Robert B Armstrong, H Lynn Starr
Affiliations
Randomized Controlled Trial

Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder

Sharon B Wigal et al. J Child Adolesc Psychopharmacol. 2011 Apr.

Abstract

Objective: To assess the effect of Osmotic-Release Oral System (OROS) methylphenidate (MPH) on a variety of measures evaluating academic performance, cognition, and social behavior in children with attention-deficit/hyperactivity disorder (ADHD).

Methods: This double-blind, randomized, placebo-controlled, crossover laboratory school study enrolled 78 children aged 9-12 years with ADHD who responded to OROS MPH. After determining individualized OROS MPH dosing (18-54 mg/day), 71 subjects received blinded treatment (OROS MPH or placebo then vice versa) on each of 2 laboratory school days, separated by 1 week. Primary efficacy was measured by Permanent Product Measure of Performance at 4 hours after study drug administration.

Results: Treatment with OROS MPH resulted in statistically significant improvement in Permanent Product Measure of Performance and Swanson, Kotkin, Agler, M-Flynn, and Pelham scores, measures of response time, and of working memory compared to placebo. Other measures did not meet all pre-established criteria for significance (maintenance of the overall type I error rate at 5%). Adverse events were consistent with previous reports of stimulant medications used in the management of ADHD. There were no discontinuations due to adverse events, and no serious adverse events or deaths.

Conclusions: OROS MPH dosed to reduce core symptoms of ADHD to within the normal range also improved performance on a variety of academic tasks in school-aged children compared to placebo. Adverse effects reported were consistent with prior studies. CLINICAL TRIAL REGISTRY INFORMATION: Double-Blind, Randomized, Placebo-Controlled, Crossover Study Evaluating the Academic, Behavioral and Cognitive Effects of Concerta on Older Children with ADHD, URL: http://clinicaltrials.gov/ct2/show/NCT00799409, unique identifier: NCT00799409.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Study design. MPH = methylphenidate; OROS = Osmotic-Release Oral System.
See this image and copyright information in PMC

References

    1. American Psychiatric Association. Text Revision (DSM-IV-TR) 4th. Washington, DC: American Psychiatric Association; 2000. Diagnostic and Statistical Manual of Mental Disorders.
    1. Barbaresi WJ. Katusic SK. Colligan RC. Weaver AL. Jacobsen SJ. Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: Does treatment with stimulant medication make a difference? Results from a population-based study. J Dev Behav Pediatr. 2007;28:274–287. - PubMed
    1. Barbaresi WJ. Katusic SK. Colligan RC. Weaver AL. Leibson CL. Jacobsen SJ. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: Results from a population-based study. J Dev Behav Pediatr. 2006;27:1–10. - PubMed
    1. Baren M. Swanson J. How not to diagnose ADHD. Contemp Pediatr. 1996;13:53–64.
    1. Bedard AC. Jain U. Hogg-Johnson S. Tannock R. Effects of methylphenidate on working memory components: Influence of measurement. J Child Psychol Psychiatry. 2007;48:872–880. - PubMed

Publication types

MeSH terms

Associated data